Corrigan Neil, Marshall Helen, Croft Julie, Copeland Joanne, Jayne David, Brown Julia
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, UK.
Department of Academic Surgery, Leeds Institute of Biological and Clinical Sciences, Clinical Sciences Building, University of Leeds, St. James's University Hospital, Leeds, LS9 7TF, UK.
Trials. 2018 Jun 27;19(1):339. doi: 10.1186/s13063-018-2726-0.
Commonly in surgical randomised controlled trials (RCT) the experimental treatment is a relatively new technique which the surgeons may still be learning, while the control is a well-established standard. This can lead to biased comparisons between treatments. In this paper we discuss the implementation of approaches for addressing this issue in the ROLARR trial, and points of consideration for future surgical trials.
ROLARR was an international, randomised, parallel-group trial comparing robotic vs. laparoscopic surgery for the curative treatment of rectal cancer. The primary endpoint was conversion to open surgery (binary). A surgeon inclusion criterion mandating a minimum level of experience in each technique was incorporated. Additionally, surgeon self-reported data were collected periodically throughout the trial to capture the level of experience of every participating surgeon. Multi-level logistic regression adjusting for operating surgeon as a random effect is used to estimate the odds ratio for conversion to open surgery between the treatment groups. We present and contrast the results from the primary analysis, which did not account for learning effects, and a sensitivity analysis which did.
The primary analysis yields an estimated odds ratio (robotic/laparoscopic) of 0.614 (95% CI 0.311, 1.211; p = 0.16), providing insufficient evidence to conclude superiority of robotic surgery compared to laparoscopic in terms of the risk of conversion to open. The sensitivity analysis reveals that while participating surgeons in ROLARR were expert at laparoscopic surgery, some, if not all, were still learning robotic surgery. The treatment-effect odds ratio decreases by a factor of 0.341 (95% CI 0.121, 0.960; p = 0.042) per unit increase in log-number of previous robotic operations performed by the operating surgeon. The odds ratio for a patient whose operating surgeon has the mean experience level in ROLARR - 152.46 previous laparoscopic, 67.93 previous robotic operations - is 0.40 (95% CI 0.168, 0.953; p = 0.039).
In this paper we have demonstrated the implementation of approaches for accounting for learning in a practical example of a surgery RCT analysis. The results demonstrate the value of implementing such approaches, since we have shown that without them the ROLARR analysis would indeed have been confounded by the learning effects.
International Standard Randomised Controlled Trial Number (ISRCTN) registry, ID: ISRCTN80500123. Registered on 27 May 2010.
在外科随机对照试验(RCT)中,通常试验性治疗是一种相对较新的技术,外科医生可能仍在学习,而对照则是一种成熟的标准。这可能导致治疗之间的比较存在偏差。在本文中,我们讨论了在ROLARR试验中解决这一问题的方法的实施情况,以及未来外科试验的考虑要点。
ROLARR是一项国际随机平行组试验,比较机器人手术与腹腔镜手术治疗直肠癌的疗效。主要终点是转为开放手术(二元变量)。纳入了一项要求外科医生在每种技术上具备最低经验水平的纳入标准。此外,在整个试验过程中定期收集外科医生自我报告的数据,以了解每位参与外科医生的经验水平。使用多水平逻辑回归,并将手术医生作为随机效应进行调整,以估计治疗组之间转为开放手术的比值比。我们展示并对比了未考虑学习效应的初步分析结果和考虑了学习效应的敏感性分析结果。
初步分析得出估计的比值比(机器人手术/腹腔镜手术)为0.614(95%置信区间0.311, 1.211;p = 0.16),没有足够证据得出机器人手术在转为开放手术风险方面优于腹腔镜手术的结论。敏感性分析表明,虽然ROLARR试验中的参与外科医生在腹腔镜手术方面是专家,但部分(如果不是全部)仍在学习机器人手术。手术医生之前进行的机器人手术对数每增加一个单位(log),治疗效果比值比降低0.341倍(95%置信区间0.121, 0.960;p = 0.042)。对于手术医生具有ROLARR试验平均经验水平(之前152.46例腹腔镜手术、67.93例机器人手术)的患者,比值比为0.40(95%置信区间0.168, 0.953;p = 0.039)。
在本文中,我们在一个外科RCT分析的实际例子中展示了考虑学习因素的方法的实施情况。结果证明了实施这些方法的价值,因为我们已经表明,如果不采用这些方法,ROLARR分析确实会受到学习效应的混淆。
国际标准随机对照试验编号(ISRCTN)注册库,编号:ISRCTN80500123。于2010年5月27日注册。